What are the causes of lymphocytosis in a 20-year-old woman with irritable bowel syndrome (constipation‑predominant)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 19, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Causes of Lymphocytosis in a 20-Year-Old Woman with IBS-C

Lymphocytosis in this clinical context most likely represents duodenal or colonic intraepithelial lymphocytosis (IEL), which is a recognized histological finding in IBS patients and does not indicate a systemic hematologic disorder.

Understanding Lymphocytosis in IBS

The term "lymphocytosis" in the context of IBS typically refers to increased intraepithelial lymphocytes found on intestinal biopsies, not peripheral blood lymphocytosis. This is an important distinction that affects clinical interpretation.

Documented Causes in IBS Patients

Low-grade mucosal inflammation is a well-established pathophysiologic mechanism in IBS 1, 2. Specifically:

  • Duodenal lymphocytosis occurs in IBS patients, with increased IEL counts compared to controls 1, 3
  • Colonic intraepithelial lymphocytosis has been documented, with significantly increased IEL numbers in IBS patients (p=0.002) 4
  • Some IBS patients (41.9%) may even meet histological criteria for lymphocytic colitis 4

Specific Mechanisms and Triggers

Post-infectious changes can drive lymphocyte infiltration:

  • Following gastroenteritis (Campylobacter, other bacterial infections), patients develop increased intraepithelial and lamina propria lymphocytes 5, 2
  • Post-infectious IBS accounts for 6-17% of total IBS cases, with relative risk of 11.9 following acute gastroenteritis 2
  • Duration of initial diarrheal illness is the strongest risk factor 2

Environmental factors may exacerbate lymphocytosis:

  • Cigarette smoking significantly increases IEL counts (54.2 ± 7.7 vs. 36.0 ± 8.8 in non-smokers, p < 0.001) 3
  • IEL counts correlate directly with duodenal expression of interferon-gamma (r = 0.36, p = 0.04) 3

Important Differential Considerations

When evaluating lymphocytosis in this patient, exclude:

  1. Celiac disease - Guidelines recommend coeliac serology as baseline testing 6, 7
  2. Microscopic colitis - Should be considered if diarrhoea develops, particularly with alarm features 6
  3. Gluten-related disorders - DQ2-8 haplotype testing may be warranted if duodenal lymphocytosis is prominent 3
  4. Infectious triggers - CMV, EBV (though these are more relevant in IBD patients on immunosuppression) 8

Clinical Approach

Baseline investigations per guidelines 6:

  • Full blood count
  • C-reactive protein
  • Coeliac serology

Additional testing if lymphocytosis is documented on biopsy:

  • Confirm whether this is peripheral blood or tissue lymphocytosis
  • If tissue lymphocytosis: assess for celiac disease, microscopic colitis
  • If peripheral blood lymphocytosis: pursue standard hematologic workup (outside scope of IBS evaluation)

Key Clinical Pitfalls

  • Do not over-investigate routine IBS-C patients without alarm symptoms - colonoscopy yield is extremely low 6
  • Age consideration: At 20 years old, this patient is well below the threshold for routine endoscopy (40-50 years per guidelines) 9
  • Recognize that IEL increase alone does not mandate aggressive intervention if other causes are excluded 4, 1

The presence of intraepithelial lymphocytosis in IBS represents a pathophysiologic marker of the disorder rather than a separate disease requiring specific treatment beyond standard IBS management 1, 2, 7.

Related Questions

How should I evaluate and manage a 25-year-old woman with a one-year history of diffuse musculoskeletal pain, severe constipation, and abdominal burning?
In a 26-year-old patient with ongoing irritable bowel syndrome flare-ups, what further management steps should be taken?
How should I evaluate and treat a 30-year-old woman with chronic lower abdominal pain, alternating diarrhea and constipation, nausea, and anxiety who has not responded to increased dietary fiber?
What is the recommended evaluation and management for a 32-year-old woman presenting with mucus-containing stools and 1–6 bowel movements daily?
What is the appropriate management for a 25-year-old female with 2 months of abdominal bloating, alternating constipation and watery stools, and normal transvaginal ultrasound, urine analysis, and routine laboratory results?
Is ketamine an appropriate rescue treatment for refractory cluster headache or migraine in adults?
In an elderly patient with Alzheimer disease taking donepezil, should the medication be continued on the day of surgery and what anesthesia precautions are recommended?
What are the positive clinical and imaging findings that indicate a serious underlying condition in a patient with severe hip pain?
What does a QT interval of 386 ms and a corrected QT (QTc) of 464 ms indicate?
How should I manage a point-of-care urine analysis showing moderate leukocytes and negative nitrites?
How should I document the disability evaluation for a patient with rheumatoid arthritis seeking disability benefits?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.